Home › FDA Approves The Patheon Site In Bourgoin, France To Manufacture Drugs For U.S. Market
 

Keywords :   


FDA Approves The Patheon Site In Bourgoin, France To Manufacture Drugs For U.S. Market

2014-05-09 16:12:50| drugdiscoveryonline News Articles

Patheon , the pharmaceutical services business owned by DPx Holdings, recently received FDA approval for its Bourgoin, France site to begin manufacturing and selling drugs to the U.S. market. The Bourgoin site specializes in development and commercial scale manufacture of solid oral forms and non-sterile liquids.

Tags: site us france market

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
15.06Atlantic Tropical Weather Outlook
15.06Eastern North Pacific Tropical Weather Outlook
15.06Atlantic Tropical Weather Outlook
15.06Eastern North Pacific Tropical Weather Outlook
14.06Bates learned of knighthood at Post Office Inquiry
14.06Chemours Publishes 2023 Sustainability Report
14.06CalPoly Hosts Polymers & Coatings Summer 2024 Short Course
14.06Washington Corner May-June 2024
More »